OND-PR002 (novel ondansetron formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OND-PR002 (novel ondansetron formulation), covering 2014-10-07 to 2014-10-07. Get the full timeline:
Most recent: Clinical Trial Update: PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND) [Phase 2]